Other Information
−Removed: Amendment, dated April 8, 2021, to the Amended and Restated Employment Agreement, dated as of November 24, 2020, by and between TherapeuticsMD, Inc.
−Removed: and John C.K.
−Removed: Milligan, IV (1)
−Removed: First Amendment to the TherapeuticsMD, Inc.
−Removed: 2019 Stock Incentive Plan ( 2 )
+Added: Executive Employment Agreement, dated as of August 3, 2021, by and between TherapeuticsMD, Inc.
+Added: and Hugh O’Dowd (1)
+Added: TherapeuticsMD, Inc.
+Added: Inducement Grant Restricted Stock Unit Agreement, dated as of August 31, 2021, by and between TherapeuticsMD, Inc.
+Added: and Hugh O’Dowd ( 2 )
+Added: Executive Employment Agreement, dated October 15, 2021, by and between TherapeuticsMD, Inc.
+Added: and Mark Glickman (3)
+Added: TherapeuticsMD, Inc.
+Added: Inducement Grant Restricted Stock Unit Agreement, dated October 15, 2021, by and between TherapeuticsMD, Inc.
+Added: and Mark Glickman (4)
+Added: Amendment to Employment Agreement between TherapeuticsMD, Inc.
+Added: D’Arecca, dated October 15, 2021
Certification of Chief Executive Officer pursuant to Rule 13a-14(a) and Rule 15d-14(a)
6 unchanged sentences
Furnished herewith.
−Removed: Filed as Exhibit 10.1 to the Company’s Current Report on Form 8-K filed with the SEC on April 12, 2021 and incorporated herein by reference (File No.
−Removed: Filed as Appendix A to the Company’s Definitive Proxy Statement on Schedule 14A filed with the SEC on April 14, 2021 and incorporated herein by reference (File No.
+Added: Filed as Exhibit 10.1 to the Company’s Current Report on Form 8-K filed with the SEC on August 9, 2021 and incorporated herein by reference (File No.
+Added: Filed as Exhibit 10.1 to the Company’s Form S-8 filed with the SEC on August 31, 2021 and incorporated herein by reference (File No.
+Added: Filed as Exhibit 10.1 to the Company’s Form S-8 filed with the SEC on October 15, 2021 and incorporated herein by reference (File No.
+Added: Filed as Exhibit 10.2 to the Company’s Form S-8 filed with the SEC on October 15, 2021 and incorporated herein by reference (File No.
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
−Removed: August 4, 2021
+Added: November 12, 2021
TherapeuticsMD, Inc.
5 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.